Bioventus Inc. financial data

Symbol
BVS on Nasdaq
Location
4721 Emperor Boulevard, Suite 100, Durham, NC
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 148 % +2.36%
Quick Ratio 51.8 % +12%
Debt-to-equity 329 % -9.98%
Return On Equity 5.22 %
Return On Assets 1.44 %
Operating Margin 8.05 %

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 177M USD +134%
Weighted Average Number of Shares Outstanding, Basic 66.9M shares +2.55%
Weighted Average Number of Shares Outstanding, Diluted 68.8M shares +5.49%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 564M USD +1.58%
Research and Development Expense 12.1M USD -13.5%
Operating Income (Loss) 45.4M USD +209%
Nonoperating Income (Expense) -30.7M USD +21.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 14.7M USD
Income Tax Expense (Benefit) 2.16M USD +12.7%
Net Income (Loss) Attributable to Parent 10.2M USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 42.2M USD -2.11%
Accounts Receivable, after Allowance for Credit Loss, Current 130M USD +6.95%
Inventory, Net 96.3M USD +6.93%
Assets, Current 281M USD -5.96%
Deferred Income Tax Assets, Net 4.75M USD -35.8%
Operating Lease, Right-of-Use Asset 5.83M USD -40.4%
Intangible Assets, Net (Excluding Goodwill) 377M USD -9.02%
Goodwill 7.46M USD 0%
Assets 702M USD -8.82%
Accounts Payable, Current 26.6M USD +58.2%
Accrued Liabilities, Current 119M USD -7.19%
Contract with Customer, Liability, Current 1.68M USD -28.5%
Liabilities, Current 162M USD -23.5%
Deferred Income Tax Liabilities, Net 786K USD
Operating Lease, Liability, Noncurrent 5.21M USD -33.1%
Other Liabilities, Noncurrent 20.5M USD -21.7%
Liabilities 494M USD -15.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.84M USD -513%
Retained Earnings (Accumulated Deficit) -350M USD +1.48%
Stockholders' Equity Attributable to Parent 166M USD +11.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 207M USD +10.9%
Liabilities and Equity 702M USD -8.82%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.3M USD -222%
Net Cash Provided by (Used in) Financing Activities 947K USD
Net Cash Provided by (Used in) Investing Activities -826K USD +17.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -18.8M USD -59.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 42.2M USD -2.11%
Deferred Tax Assets, Valuation Allowance 51.9M USD +12.8%
Deferred Tax Assets, Gross 56.6M USD +20.9%
Operating Lease, Liability 8.74M USD -19.8%
Payments to Acquire Property, Plant, and Equipment 826K USD +184%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 7.89M USD
Lessee, Operating Lease, Liability, to be Paid 10.9M USD -32.2%
Operating Lease, Liability, Current 3.53M USD +13.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.33M USD -18.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.49M USD -23.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 810K USD -41%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.66M USD -18.1%
Deferred Tax Assets, Operating Loss Carryforwards 9.22M USD -14.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 3.74M USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.37M USD -47.8%
Operating Lease, Payments 892K USD -24.3%
Additional Paid in Capital 518M USD +2.86%
Depreciation, Depletion and Amortization 11.9M USD +0.68%
Deferred Tax Assets, Net of Valuation Allowance 4.75M USD +465%
Share-based Payment Arrangement, Expense 7.92M USD +27.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%